Annual Net Income
-$559.00 M
+$1.89 B+77.15%
31 December 2023
Summary:
Teva Pharmaceutical Industries Limited annual net profit is currently -$559.00 million, with the most recent change of +$1.89 billion (+77.15%) on 31 December 2023. During the last 3 years, it has risen by +$3.43 billion (+85.99%). TEVA annual net income is now -116.78% below its all-time high of $3.33 billion, reached on 31 December 2010.TEVA Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
-$437.00 M
+$409.00 M+48.35%
30 September 2024
Summary:
Teva Pharmaceutical Industries Limited quarterly net profit is currently -$437.00 million, with the most recent change of +$409.00 million (+48.35%) on 30 September 2024. Over the past year, it has dropped by -$506.00 million (-733.33%). TEVA quarterly net income is now -139.02% below its all-time high of $1.12 billion, reached on 31 March 2018.TEVA Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
-$959.00 M
-$506.00 M-111.70%
30 September 2024
Summary:
Teva Pharmaceutical Industries Limited TTM net profit is currently -$959.00 million, with the most recent change of -$506.00 million (-111.70%) on 30 September 2024. Over the past year, it has increased by +$1.38 billion (+58.96%). TEVA TTM net income is now -128.38% below its all-time high of $3.38 billion, reached on 31 March 2011.TEVA TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TEVA Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +77.2% | -733.3% | +59.0% |
| 3 y3 years | +86.0% | -249.7% | -232.1% |
| 5 y5 years | +74.0% | -39.2% | +76.0% |
TEVA Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -234.1% | +86.0% | -194.4% | +66.7% | -232.1% | +60.8% |
| 5 y | 5 years | -234.1% | +86.0% | -194.4% | +90.0% | -232.1% | +76.2% |
| alltime | all time | -116.8% | +96.6% | -139.0% | +96.2% | -128.4% | +94.1% |
Teva Pharmaceutical Industries Limited Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$437.00 M(-48.3%) | -$959.00 M(+111.7%) |
| June 2024 | - | -$846.00 M(+508.6%) | -$453.00 M(-5.4%) |
| Mar 2024 | - | -$139.00 M(-130.0%) | -$479.00 M(-14.5%) |
| Dec 2023 | -$559.00 M(-77.1%) | $463.00 M(+571.0%) | -$560.00 M(-76.0%) |
| Sept 2023 | - | $69.00 M(-107.9%) | -$2.34 B(-0.6%) |
| June 2023 | - | -$872.00 M(+296.4%) | -$2.35 B(+37.4%) |
| Mar 2023 | - | -$220.00 M(-83.3%) | -$1.71 B(-30.1%) |
| Dec 2022 | -$2.45 B(-686.6%) | -$1.31 B(-2446.4%) | -$2.44 B(+89.5%) |
| Sept 2022 | - | $56.00 M(-124.1%) | -$1.29 B(+22.4%) |
| June 2022 | - | -$232.00 M(-75.7%) | -$1.05 B(+71.4%) |
| Mar 2022 | - | -$955.00 M(+500.6%) | -$615.00 M(-247.5%) |
| Dec 2021 | $417.00 M(-110.5%) | -$159.00 M(-154.5%) | $417.00 M(-42.6%) |
| Sept 2021 | - | $292.00 M(+41.1%) | $726.00 M(-118.5%) |
| June 2021 | - | $207.00 M(+168.8%) | -$3.92 B(-1.7%) |
| Mar 2021 | - | $77.00 M(-48.7%) | -$3.98 B(-0.2%) |
| Dec 2020 | -$3.99 B(+299.4%) | $150.00 M(-103.4%) | -$3.99 B(-1.0%) |
| Sept 2020 | - | -$4.35 B(-3206.4%) | -$4.03 B(<-9900.0%) |
| June 2020 | - | $140.00 M(+102.9%) | $4.00 M(-100.5%) |
| Mar 2020 | - | $69.00 M(-36.7%) | -$825.00 M(-17.4%) |
| Dec 2019 | -$999.00 M(-53.5%) | $109.00 M(-134.7%) | -$999.00 M(-75.0%) |
| Sept 2019 | - | -$314.00 M(-54.4%) | -$3.99 B(+2.7%) |
| June 2019 | - | -$689.00 M(+556.2%) | -$3.89 B(+15.2%) |
| Mar 2019 | - | -$105.00 M(-96.4%) | -$3.38 B(+57.0%) |
| Dec 2018 | -$2.15 B(-86.8%) | -$2.89 B(+1287.5%) | -$2.15 B(-80.1%) |
| Sept 2018 | - | -$208.00 M(+18.2%) | -$10.80 B(+8.0%) |
| June 2018 | - | -$176.00 M(-115.7%) | -$10.00 B(-36.7%) |
| Mar 2018 | - | $1.12 B(-109.7%) | -$15.79 B(-2.9%) |
| Dec 2017 | -$16.27 B(-5043.8%) | -$11.54 B(-2038.7%) | -$16.27 B(+185.2%) |
| Sept 2017 | - | $595.00 M(-110.0%) | -$5.70 B(-3.1%) |
| June 2017 | - | -$5.97 B(-1025.6%) | -$5.89 B(-1841.4%) |
| Mar 2017 | - | $645.00 M(-166.3%) | $338.00 M(+2.7%) |
| Dec 2016 | $329.00 M(-79.3%) | -$973.00 M(-336.2%) | $329.00 M(-81.7%) |
| Sept 2016 | - | $412.00 M(+62.2%) | $1.80 B(+20.7%) |
| June 2016 | - | $254.00 M(-60.1%) | $1.49 B(-16.0%) |
| Mar 2016 | - | $636.00 M(+27.2%) | $1.78 B(+12.0%) |
| Dec 2015 | $1.59 B(-48.0%) | $500.00 M(+385.4%) | $1.59 B(-10.5%) |
| Sept 2015 | - | $103.00 M(-80.9%) | $1.77 B(-30.3%) |
| June 2015 | - | $539.00 M(+20.9%) | $2.55 B(-7.6%) |
| Mar 2015 | - | $446.00 M(-35.1%) | $2.76 B(-9.8%) |
| Dec 2014 | $3.06 B(+140.7%) | $687.00 M(-21.6%) | $3.06 B(+11.2%) |
| Sept 2014 | - | $876.00 M(+17.1%) | $2.75 B(+6.4%) |
| June 2014 | - | $748.00 M(+0.5%) | $2.58 B(+86.8%) |
| Mar 2014 | - | $744.00 M(+95.8%) | $1.38 B(+9.0%) |
| Dec 2013 | $1.27 B(-35.4%) | $380.00 M(-46.6%) | $1.27 B(+5.0%) |
| Sept 2013 | - | $711.00 M(-257.3%) | $1.21 B(+188.5%) |
| June 2013 | - | -$452.00 M(-171.7%) | $419.00 M(-75.8%) |
| Mar 2013 | - | $630.00 M(+96.9%) | $1.73 B(-11.7%) |
| Dec 2012 | $1.96 B(-28.9%) | $320.00 M(-505.1%) | $1.96 B(-8.7%) |
| Sept 2012 | - | -$79.00 M(-109.2%) | $2.15 B(-31.6%) |
| June 2012 | - | $863.00 M(+0.5%) | $3.14 B(+10.0%) |
| Mar 2012 | - | $859.00 M(+69.8%) | $2.86 B(+3.6%) |
| Dec 2011 | $2.76 B(-17.2%) | $506.00 M(-44.8%) | $2.76 B(-8.8%) |
| Sept 2011 | - | $916.00 M(+59.0%) | $3.02 B(-4.2%) |
| June 2011 | - | $576.00 M(-24.3%) | $3.16 B(-6.5%) |
| Mar 2011 | - | $761.00 M(-1.3%) | $3.38 B(+1.4%) |
| Dec 2010 | $3.33 B(+66.5%) | $771.00 M(-26.6%) | $3.33 B(+13.3%) |
| Sept 2010 | - | $1.05 B(+31.7%) | $2.94 B(+15.8%) |
| June 2010 | - | $797.00 M(+11.8%) | $2.54 B(+12.2%) |
| Mar 2010 | - | $713.00 M(+88.1%) | $2.26 B(+13.1%) |
| Dec 2009 | $2.00 B(+215.0%) | $379.00 M(-41.6%) | $2.00 B(+114.4%) |
| Sept 2009 | - | $649.00 M(+24.6%) | $933.00 M(+1.3%) |
| June 2009 | - | $521.00 M(+15.5%) | $921.00 M(-1.9%) |
| Mar 2009 | - | $451.00 M(-165.6%) | $939.00 M(+47.9%) |
| Dec 2008 | $635.00 M(-67.5%) | -$688.00 M(-208.0%) | $635.00 M(-66.5%) |
| Sept 2008 | - | $637.00 M(+18.2%) | $1.89 B(+6.3%) |
| June 2008 | - | $539.00 M(+266.7%) | $1.78 B(+1.4%) |
| Mar 2008 | - | $147.00 M(-74.2%) | $1.76 B(-10.0%) |
| Dec 2007 | $1.95 B(+257.5%) | $570.00 M(+8.6%) | $1.95 B(+6.0%) |
| Sept 2007 | - | $525.00 M(+1.9%) | $1.84 B(-4.2%) |
| June 2007 | - | $515.00 M(+50.6%) | $1.92 B(+1.4%) |
| Mar 2007 | - | $342.00 M(-25.6%) | $1.90 B(+247.6%) |
| Dec 2006 | $546.00 M(-49.1%) | $459.90 M(-24.2%) | $545.70 M(+39.8%) |
| Sept 2006 | - | $606.40 M(+24.2%) | $390.40 M(+664.0%) |
| June 2006 | - | $488.40 M(-148.4%) | $51.10 M(-126.1%) |
| Mar 2006 | - | -$1.01 B(-431.3%) | -$196.10 M(-118.3%) |
| Dec 2005 | $1.07 B | $304.60 M(+14.0%) | $1.07 B(+2.4%) |
| Sept 2005 | - | $267.10 M(+10.7%) | $1.05 B(+1.5%) |
| June 2005 | - | $241.20 M(-6.9%) | $1.03 B(+1.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2005 | - | $259.10 M(-7.1%) | $1.02 B(+207.0%) |
| Dec 2004 | $332.00 M(-52.0%) | $279.00 M(+10.9%) | $332.00 M(+38.7%) |
| Sept 2004 | - | $251.50 M(+9.6%) | $239.30 M(+65.7%) |
| June 2004 | - | $229.50 M(-153.6%) | $144.40 M(+15.2%) |
| Mar 2004 | - | -$428.00 M(-329.7%) | $125.30 M(-81.9%) |
| Dec 2003 | $691.00 M(+68.4%) | $186.30 M(+19.0%) | $691.00 M(+7.8%) |
| Sept 2003 | - | $156.60 M(-25.6%) | $641.20 M(+10.4%) |
| June 2003 | - | $210.40 M(+52.8%) | $580.90 M(+25.6%) |
| Mar 2003 | - | $137.70 M(+0.9%) | $462.40 M(+12.7%) |
| Dec 2002 | $410.30 M(+47.5%) | $136.50 M(+41.7%) | $410.30 M(+16.1%) |
| Sept 2002 | - | $96.30 M(+4.8%) | $353.41 M(+5.0%) |
| June 2002 | - | $91.90 M(+7.4%) | $336.51 M(+8.9%) |
| Mar 2002 | - | $85.60 M(+7.5%) | $309.06 M(+11.1%) |
| Dec 2001 | $278.21 M(+87.5%) | $79.61 M(+0.3%) | $278.21 M(+9.7%) |
| Sept 2001 | - | $79.40 M(+23.2%) | $253.55 M(+14.9%) |
| June 2001 | - | $64.45 M(+17.7%) | $220.76 M(+33.5%) |
| Mar 2001 | - | $54.75 M(-0.4%) | $165.30 M(+11.4%) |
| Dec 2000 | $148.42 M(+27.1%) | $54.95 M(+17.9%) | $148.42 M(+12.1%) |
| Sept 2000 | - | $46.61 M(+418.2%) | $132.44 M(+27.1%) |
| June 2000 | - | $8.99 M(-76.2%) | $104.24 M(-17.5%) |
| Mar 2000 | - | $37.86 M(-2.9%) | $126.34 M(+8.2%) |
| Dec 1999 | $116.78 M(+64.9%) | $38.98 M(+111.8%) | $116.78 M(+43.8%) |
| Sept 1999 | - | $18.40 M(-40.8%) | $81.20 M(-7.8%) |
| June 1999 | - | $31.10 M(+9.9%) | $88.10 M(+18.9%) |
| Mar 1999 | - | $28.30 M(+731.6%) | $74.10 M(+4.5%) |
| Dec 1998 | $70.80 M(-30.2%) | $3.40 M(-86.5%) | $70.90 M(+4.6%) |
| Sept 1998 | - | $25.30 M(+48.0%) | $67.80 M(-13.4%) |
| June 1998 | - | $17.10 M(-31.9%) | $78.30 M(-17.8%) |
| Mar 1998 | - | $25.10 M(+8266.7%) | $95.20 M(-6.3%) |
| Dec 1997 | $101.50 M(+38.3%) | $300.00 K(-99.2%) | $101.60 M(-22.7%) |
| Sept 1997 | - | $35.80 M(+5.3%) | $131.50 M(+9.9%) |
| June 1997 | - | $34.00 M(+7.9%) | $119.60 M(+44.8%) |
| Mar 1997 | - | $31.50 M(+4.3%) | $82.60 M(+12.5%) |
| Dec 1996 | $73.40 M(+4.4%) | $30.20 M(+26.4%) | $73.40 M(+37.2%) |
| Sept 1996 | - | $23.90 M(-896.7%) | $53.50 M(+4.5%) |
| June 1996 | - | -$3.00 M(-113.5%) | $51.20 M(-30.5%) |
| Mar 1996 | - | $22.30 M(+116.5%) | $73.70 M(+4.8%) |
| Dec 1995 | $70.30 M(+4.0%) | $10.30 M(-52.3%) | $70.30 M(-6.1%) |
| Sept 1995 | - | $21.60 M(+10.8%) | $74.90 M(+5.8%) |
| June 1995 | - | $19.50 M(+3.2%) | $70.80 M(+1.9%) |
| Mar 1995 | - | $18.90 M(+26.8%) | $69.50 M(+2.7%) |
| Dec 1994 | $67.60 M(+17.6%) | $14.90 M(-14.9%) | $67.70 M(-1.9%) |
| Sept 1994 | - | $17.50 M(-3.8%) | $69.00 M(+5.5%) |
| June 1994 | - | $18.20 M(+6.4%) | $65.40 M(+7.0%) |
| Mar 1994 | - | $17.10 M(+5.6%) | $61.10 M(+6.3%) |
| Dec 1993 | $57.50 M(+81.4%) | $16.20 M(+16.5%) | $57.50 M(+10.8%) |
| Sept 1993 | - | $13.90 M(0.0%) | $51.90 M(+16.1%) |
| June 1993 | - | $13.90 M(+3.0%) | $44.70 M(+18.3%) |
| Mar 1993 | - | $13.50 M(+27.4%) | $37.80 M(+18.1%) |
| Dec 1992 | $31.70 M(+33.8%) | $10.60 M(+58.2%) | $32.00 M(+12.7%) |
| Sept 1992 | - | $6.70 M(-4.3%) | $28.40 M(+7.6%) |
| June 1992 | - | $7.00 M(-9.1%) | $26.40 M(+0.8%) |
| Mar 1992 | - | $7.70 M(+10.0%) | $26.20 M(+10.5%) |
| Dec 1991 | $23.70 M(+13.9%) | $7.00 M(+48.9%) | $23.70 M(-9.5%) |
| Sept 1991 | - | $4.70 M(-30.9%) | $26.20 M(+4.8%) |
| June 1991 | - | $6.80 M(+30.8%) | $25.00 M(+14.2%) |
| Mar 1991 | - | $5.20 M(-45.3%) | $21.90 M(+3.3%) |
| Dec 1990 | $20.80 M(+23.1%) | $9.50 M(+171.4%) | $21.20 M(+26.9%) |
| Sept 1990 | - | $3.50 M(-5.4%) | $16.70 M(0.0%) |
| June 1990 | - | $3.70 M(-17.8%) | $16.70 M(+1.2%) |
| Mar 1990 | - | $4.50 M(-10.0%) | $16.50 M(-2.4%) |
| Dec 1989 | $16.90 M(+40.8%) | $5.00 M(+42.9%) | $16.90 M(+15.8%) |
| Sept 1989 | - | $3.50 M(0.0%) | $14.60 M(+10.6%) |
| June 1989 | - | $3.50 M(-28.6%) | $13.20 M(-0.8%) |
| Mar 1989 | - | $4.90 M(+81.5%) | $13.30 M(+10.8%) |
| Dec 1988 | $12.00 M(-18.9%) | $2.70 M(+28.6%) | $12.00 M(+29.0%) |
| Sept 1988 | - | $2.10 M(-41.7%) | $9.30 M(-7.0%) |
| June 1988 | - | $3.60 M(0.0%) | $10.00 M(+8.7%) |
| Mar 1988 | - | $3.60 M(+28.6%) | $9.20 M(-29.2%) |
| Sept 1987 | - | $2.80 M(0.0%) | $13.00 M(-6.5%) |
| June 1987 | - | $2.80 M(-24.3%) | $13.90 M(-6.1%) |
| Mar 1987 | $14.80 M(+94.7%) | $3.70 M(0.0%) | $14.80 M(+13.8%) |
| Dec 1986 | - | $3.70 M(0.0%) | $13.00 M(+16.1%) |
| Sept 1986 | - | $3.70 M(0.0%) | $11.20 M(+19.1%) |
| June 1986 | - | $3.70 M(+94.7%) | $9.40 M(+23.7%) |
| Mar 1986 | $7.60 M | $1.90 M(0.0%) | $7.60 M(+33.3%) |
| Dec 1985 | - | $1.90 M(0.0%) | $5.70 M(+50.0%) |
| Sept 1985 | - | $1.90 M(0.0%) | $3.80 M(+100.0%) |
| June 1985 | - | $1.90 M | $1.90 M |
FAQ
- What is Teva Pharmaceutical Industries Limited annual net profit?
- What is the all time high annual net income for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited annual net income year-on-year change?
- What is Teva Pharmaceutical Industries Limited quarterly net profit?
- What is the all time high quarterly net income for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited quarterly net income year-on-year change?
- What is Teva Pharmaceutical Industries Limited TTM net profit?
- What is the all time high TTM net income for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited TTM net income year-on-year change?
What is Teva Pharmaceutical Industries Limited annual net profit?
The current annual net income of TEVA is -$559.00 M
What is the all time high annual net income for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high annual net profit is $3.33 B
What is Teva Pharmaceutical Industries Limited annual net income year-on-year change?
Over the past year, TEVA annual net profit has changed by +$1.89 B (+77.15%)
What is Teva Pharmaceutical Industries Limited quarterly net profit?
The current quarterly net income of TEVA is -$437.00 M
What is the all time high quarterly net income for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high quarterly net profit is $1.12 B
What is Teva Pharmaceutical Industries Limited quarterly net income year-on-year change?
Over the past year, TEVA quarterly net profit has changed by -$506.00 M (-733.33%)
What is Teva Pharmaceutical Industries Limited TTM net profit?
The current TTM net income of TEVA is -$959.00 M
What is the all time high TTM net income for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high TTM net profit is $3.38 B
What is Teva Pharmaceutical Industries Limited TTM net income year-on-year change?
Over the past year, TEVA TTM net profit has changed by +$1.38 B (+58.96%)